Background mucosal inflammation at CRC diagnosis is linked to worse recurrence-free and cancer-specific survival in ulcerative colitis.

Individuals with CD who received treatment with biologics preoperatively have improved endoscopic outcomes when switching to a different biologic postoperatively.

A new tool can help physicians determine which patients with localized pancreatic neuroendocrine tumors (PanNETs) have an ...

James Stewart puts on his rollerblades to get ready to do the trail in Rabb Park on his day off. He continues to be able to be active because of a new treatment for bladder cancer. Last year, at 39, ...

The new risk score could help better manage the follow-up care for patients who've had pancreatic tumors surgically removed, and whose cancers have not spread to their lymph nodes, researchers wrote ...

The score could help better manage the follow-up care for patients who’ve had pancreatic tumors surgically removed, and whose cancers have not spread to their lymph nodes, researchers wrote Dec. 17 in ...

The 13-point risk score can help doctors more closely monitor patients at higher risk About 10% of patients suffer a cancer recurrence, most often in their liver FRIDAY, Dec. 19, 2025 (HealthDay News) ...

SAN ANTONIO – An artificial intelligence (AI) model created by integrating clinical, molecular, and histopathological data significantly improved recurrence risk stratification in hormone receptor (HR ...

An artificial intelligence (AI) model created by integrating clinical, molecular, and histopathological data significantly improved recurrence risk stratification in hormone receptor (HR)-positive, ...

—For certain older patients with low-genomic-risk, early-stage breast cancer, the findings from a new study suggest that some of them may be able to forgo either radiotherapy or endocrine therapy ...